Japan’s Kobayashi Pharmaceutical Co. Ltd. is set to expand its offering in the US consumer health market with the acquisition of Niles, IL-based Alva-Amco Pharmacal Companies, Inc. for $108m. The transaction is slated to close by the end of October 2020.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?